قالب وردپرس درنا توس
Home / Business / Regeneron halted the COVID-19 treatment trials in sick patients

Regeneron halted the COVID-19 treatment trials in sick patients



(Photo by David Ramos / Getty Images)

GO TO the newsroom
UPDATE 3:50 PM PT – Friday, October 30, 2020

‘Regeneron’ has suspended testing in the most ill-fated patients due to safety concerns.

According to reports on Friday, the pharmaceutical company has decided to stop providing antibodies to coronavirus patients on ventilators or those receiving high oxygen levels.

However, the company says it will continue to test patients with milder illnesses.

This happened when another pharmaceutical company, ‘Eli Lilly,’ ended its trial on hospitalized patients on Monday after the drug was found to be ineffective for severe cases of coronavirus.

MORE NEWS: The FBI hired outside contractors to overhaul the use of the FISA spy tool




Source link